333 related articles for article (PubMed ID: 28623376)
1. EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies.
Aide N; Lasnon C; Veit-Haibach P; Sera T; Sattler B; Boellaard R
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(Suppl 1):17-31. PubMed ID: 28623376
[TBL] [Abstract][Full Text] [Related]
2. Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.
Houdu B; Lasnon C; Licaj I; Thomas G; Do P; Guizard AV; Desmonts C; Aide N
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):421-428. PubMed ID: 30218317
[TBL] [Abstract][Full Text] [Related]
3. EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems.
Kaalep A; Sera T; Oyen W; Krause BJ; Chiti A; Liu Y; Boellaard R
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):412-422. PubMed ID: 29192365
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures.
Makris NE; Huisman MC; Kinahan PE; Lammertsma AA; Boellaard R
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1507-15. PubMed ID: 23754762
[TBL] [Abstract][Full Text] [Related]
5. EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program.
Lasnon C; Quak E; Le Roux PY; Robin P; Hofman MS; Bourhis D; Callahan J; Binns DS; Desmonts C; Salaun PY; Hicks RJ; Aide N
EJNMMI Phys; 2017 Dec; 4(1):17. PubMed ID: 28560574
[TBL] [Abstract][Full Text] [Related]
6. Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction.
Lasnon C; Salomon T; Desmonts C; Dô P; Oulkhouir Y; Madelaine J; Aide N
Ann Nucl Med; 2017 Feb; 31(2):125-134. PubMed ID: 27812791
[TBL] [Abstract][Full Text] [Related]
7. Impact of the EARL harmonization program on automatic delineation of metabolic active tumour volumes (MATVs).
Lasnon C; Enilorac B; Popotte H; Aide N
EJNMMI Res; 2017 Dec; 7(1):30. PubMed ID: 28361349
[TBL] [Abstract][Full Text] [Related]
8. The use of a proposed updated EARL harmonization of
Ly J; Minarik D; Edenbrandt L; Wollmer P; Trägårdh E
EJNMMI Res; 2019 Jul; 9(1):65. PubMed ID: 31346805
[TBL] [Abstract][Full Text] [Related]
9. SUV Harmonization Between Different Hybrid PET/CT Systems.
Rubello D; Colletti PM
Clin Nucl Med; 2018 Nov; 43(11):811-814. PubMed ID: 30199381
[TBL] [Abstract][Full Text] [Related]
10.
Lasnon C; Majdoub M; Lavigne B; Do P; Madelaine J; Visvikis D; Hatt M; Aide N
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2324-2335. PubMed ID: 27325312
[TBL] [Abstract][Full Text] [Related]
11. How Often Do We Fail to Classify the Treatment Response with [
Mattoli MV; Calcagni ML; Taralli S; Indovina L; Spottiswoode BS; Giordano A
Mol Imaging Biol; 2019 Dec; 21(6):1210-1219. PubMed ID: 30850971
[TBL] [Abstract][Full Text] [Related]
12. Harmonization based on quantitative analysis of standardized uptake value variations across PET/CT scanners: a multicenter phantom study.
Monsef A; Ay MR; Sheikhzadeh P; Geramifar P; Rahmim A; Ghafarian P
Nucl Med Commun; 2022 Sep; 43(9):1004-1014. PubMed ID: 35836388
[TBL] [Abstract][Full Text] [Related]
13. Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic Monitoring.
Minamimoto R; Fayad L; Advani R; Vose J; Macapinlac H; Meza J; Hankins J; Mottaghy F; Juweid M; Quon A
Radiology; 2016 Jul; 280(1):220-9. PubMed ID: 26854705
[TBL] [Abstract][Full Text] [Related]
14. Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET.
van der Vos CS; Koopman D; Rijnsdorp S; Arends AJ; Boellaard R; van Dalen JA; Lubberink M; Willemsen ATM; Visser EP
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(Suppl 1):4-16. PubMed ID: 28687866
[TBL] [Abstract][Full Text] [Related]
15. Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients.
Lasnon C; Desmonts C; Quak E; Gervais R; Do P; Dubos-Arvis C; Aide N
Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):985-96. PubMed ID: 23564036
[TBL] [Abstract][Full Text] [Related]
16. Semi-automated
Keijzer K; Niezink AGH; de Boer JW; van Doesum JA; Noordzij W; van Meerten T; van Dijk LV
Comput Struct Biotechnol J; 2023; 21():1102-1114. PubMed ID: 36789266
[TBL] [Abstract][Full Text] [Related]
17. Implications of the Harmonization of [
Jiménez-Ortega E; Agüera R; Ureba A; Balcerzyk M; Wals-Zurita A; García-Gómez FJ; Leal A
Tomography; 2022 Apr; 8(2):1097-1112. PubMed ID: 35448724
[TBL] [Abstract][Full Text] [Related]
18. TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib.
Ho KC; Fang YD; Chung HW; Liu YC; Chang JW; Hou MM; Yang CT; Cheng NM; Su TP; Yen TC
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2155-2165. PubMed ID: 27260520
[TBL] [Abstract][Full Text] [Related]
19. From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.
Wahl RL; Jacene H; Kasamon Y; Lodge MA
J Nucl Med; 2009 May; 50 Suppl 1(Suppl 1):122S-50S. PubMed ID: 19403881
[TBL] [Abstract][Full Text] [Related]
20. Does PET SUV Harmonization Affect PERCIST Response Classification?
Quak E; Le Roux PY; Lasnon C; Robin P; Hofman MS; Bourhis D; Callahan J; Binns DS; Desmonts C; Salaun PY; Hicks RJ; Aide N
J Nucl Med; 2016 Nov; 57(11):1699-1706. PubMed ID: 27283930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]